STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib

MLA

Fang Ting Lu, et al. “STAT3-Mediated Attenuation of CCl4-Induced Mouse Liver Fibrosis by the Protein Kinase Inhibitor Sorafenib.” Journal of Autoimmunity, vol. 46, Oct. 2013, pp. 25–34. EBSCOhost, https://doi.org/10.1016/j.jaut.2013.07.008.

APA

Fang Ting Lu, Xiao-Song He, M. Eric Gershwin, Wei Yang, Yan Ru Deng, Hong Di Ma, Koichi Tsuneyama, Yin Hu Wang, Anna Mae Diehl, Cheng Hai Liu, Ping Liu, & Zhe-Xiong Lian. (2013). STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. Journal of Autoimmunity, 46, 25–34. https://doi.org/10.1016/j.jaut.2013.07.008

Chicago

Fang Ting Lu, Xiao-Song He, M. Eric Gershwin, Wei Yang, Yan Ru Deng, Hong Di Ma, Koichi Tsuneyama, et al. 2013. “STAT3-Mediated Attenuation of CCl4-Induced Mouse Liver Fibrosis by the Protein Kinase Inhibitor Sorafenib.” Journal of Autoimmunity 46 (October): 25–34. doi:10.1016/j.jaut.2013.07.008.